Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Paul Vigano Sells 7,000,000 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 7,000,000 shares of the stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider directly owned 252,899 shares in the company, valued at $1,578,089.76. This trade represents a 96.51% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Stock Up 0.8%

Shares of NASDAQ AVAH opened at $6.68 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a market capitalization of $1.45 billion, a PE ratio of 5.66, a price-to-earnings-growth ratio of 0.74 and a beta of 1.93. The stock’s fifty day simple moving average is $6.79 and its two-hundred day simple moving average is $7.72. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.73 and a 12-month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.05. The business had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business’s revenue for the quarter was up 15.9% compared to the same quarter last year. As a group, analysts expect that Aveanna Healthcare Holdings Inc. will post 0.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on AVAH shares. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research report on Wednesday. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. BMO Capital Markets dropped their target price on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Weiss Ratings cut Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Finally, Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price on the stock in a research report on Friday, March 20th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $10.50.

Institutional Trading of Aveanna Healthcare

A number of institutional investors have recently made changes to their positions in the business. Segall Bryant & Hamill LLC boosted its position in shares of Aveanna Healthcare by 425.8% in the 1st quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after purchasing an additional 132,779 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Aveanna Healthcare by 64.2% in the 1st quarter. Bank of America Corp DE now owns 402,510 shares of the company’s stock worth $2,592,000 after purchasing an additional 157,368 shares in the last quarter. Smith Group Asset Management LLC boosted its position in shares of Aveanna Healthcare by 34.3% in the 1st quarter. Smith Group Asset Management LLC now owns 263,669 shares of the company’s stock worth $1,698,000 after purchasing an additional 67,393 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Aveanna Healthcare by 22.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock worth $113,000 after purchasing an additional 3,172 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its position in shares of Aveanna Healthcare by 56.3% in the 1st quarter. The Manufacturers Life Insurance Company now owns 36,509 shares of the company’s stock worth $235,000 after purchasing an additional 13,155 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.